FILGOTINIB FOR RHEUMATOID ARTHRITIS: AN OBSERVATIONAL COHORT TO ASSESS CLINICAL EFFECTIVENESS IN A SINGLE CENTRE

被引：0
|
作者：
Box, Christopher D. [1 ]
Ramsay, Susan [1 ]
McKay, Neil D. [1 ]
机构：
[1] NHS Lothian, Edinburgh Rheumatol Res Grp, Edinburgh, Midlothian, Scotland
来源：
RHEUMATOLOGY | 2024年 / 63卷
关键词：
D O I：
10.1093/rheumatology/keae163.149
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FILGOTINIB FOR RHEUMATOID ARTHRITIS: AN OBSERVATIONAL COHORT TO ASSESS CLINICAL EFFECTIVENESS IN A SINGLE CENTRE
    Box, Christopher D.
    Ramsay, Susan
    McKay, Neil D.
    RHEUMATOLOGY, 2024, 63
  • [2] LEFILGOTINIB FOR RHEUMATOID ARTHRITIS - AN OBSERVATIONAL STUDY TO ASSESS CLINICAL EFFECTIVENESS IN NHS LOTHIAN
    Box, C.
    Swann, E.
    Harris, H.
    Mckay, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1429 - 1429
  • [3] REAL-WORLD EFFECTIVENESS OF FILGOTINIB IN BELGIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Diederik, D. C.
    Durez, P.
    Lenaerts, J.
    Westhovens, R.
    Verschueren, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1401 - 1401
  • [4] Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights
    Raimondo, Maria Gabriella
    Biggioggero, Martina
    Coletto, Lavinia Agra
    Ramming, Andreas
    Caporali, Roberto
    Favalli, Ennio Giulio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (06) : 661 - 670
  • [5] Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience
    Jose Ramon Maneiro
    Eva Perez-Pampin
    Eva Salgado
    Loreto Carmona
    Juan J. Gomez-Reino
    Rheumatology International, 2014, 34 : 1059 - 1063
  • [6] Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience
    Ramon Maneiro, Jose
    Perez-Pampin, Eva
    Salgado, Eva
    Carmona, Loreto
    Gomez-Reino, Juan J.
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (08) : 1059 - 1063
  • [7] A descriptive observational cohort study to assess effectiveness of risk minimization activities in baricitinib incident users treated for rheumatoid arthritis in Nordic countries
    Ankarfeldt, Mikkel Zollner
    Soltoft-Jensen, Aleksander
    Doser, Karoline
    Pukkala, Eero
    Bolin, Kristian
    Petersen, Janne
    Jimenez-Solem, Espen
    Flege, Marius M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 105 - 106
  • [8] Real-Life Use of Filgotinib in Rheumatoid Arthritis: A Retrospective Cohort Study
    Raimondo, Vincenzo
    Caminiti, Maurizio
    Olivo, Domenico
    Gigliotti, Pietro
    L'Andolina, Massimo
    Muto, Pietro
    Pellegrini, Roberta
    Varcasia, Giuseppe
    Bruno, Caterina
    Massaro, Laura
    Mariano, Giuseppa Pagano
    Luppino, Jessica Maria Elisa
    Cirillo, Mariateresa
    Caira, Virginia
    Calabria, Marilena
    Ciaffi, Jacopo
    Ferri, Clodoveo
    Ursini, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [9] Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience
    La Barbera, L.
    Rizzo, C.
    Camarda, F.
    Atzeni, F.
    Miceli, G.
    Colella, A. B. Molica
    Franchina, V.
    Giardina, A.
    Corrao, S.
    Provenzano, G.
    Bursi, R.
    Foti, R.
    Dal Bosco, Y.
    Debilio, C.
    Luppino, F.
    Colaci, M.
    Aprile, M. L.
    Bentivegna, M.
    Cassara, E.
    Lo Gullo, A.
    De Andres, M. I.
    Guggino, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (05) : 991 - 998
  • [10] INTERIM UPDATE ON BASELINE CHARACTERISTICS AND EFFECTIVENESS FROM A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH FILGOTINIB (FILOSOPHY)
    Caporali, R.
    Avouac, J.
    Bevers, K.
    Burmester, G. R.
    Debray, T.
    De Leonardis, F.
    Harris, K.
    Betteridge, N.
    Romero-Yuste, S.
    Verschueren, P.
    Zignani, M.
    Galloway, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 491 - 491
12345